Table 1.
Polygenic risk score of men predicting prostate cancer in Finland*.
| SAMPLE GROUPS | N | Mean (95% CI) | St error of mean | Median | Variance | Standard deviation |
|---|---|---|---|---|---|---|
| Study population | 5138 | 5.99 (5.83–6.16) | 0.085 | 5.01 | 37.05 | 6.09 |
| Men without prostate cancer (controls) (FinRSPC) | 2400 | 4.71 (4.47–4.94) | 0.119 | 3.83 | 33.68 | 5.80 |
| Men with prostate cancer (cases) | 2738 | 7.12 (6.89–7.35) | 0.117 | 6.59 | 37.28 | 6.11 |
| Screening trial cases (FinRSPC) | 455 | 6.65 (6.09–7.20) | 0.282 | 6.31 | 36.22 | 6.02 |
| Clinical cases (Pirkanmaa Hospital) | 2283 | 7.22 (6.97–7.47) | 0.128 | 6.74 | 37.45 | 6.12 |
*Polygenic risk score is based on 55 prostate cancer susceptibility loci.